Pharmacological modulation of lateral habenular dopamine D2 receptors alters the anxiogenic response to cocaine in a runway model of drug self-administration

Behavioural Brain Research

Volumn 310, Issue , 2016, Pages 42-50

  Shelton, Kerisa ^a   Bogyo, Kelsie ^a   Schick, Tinisha ^a   Ettenberg, Aaron ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Cis flupenthixol; Cocaine; Lateral habenula; Runway self administration; Sumanirole

Indexed keywords

COCAINE; DOPAMINE 2 RECEPTOR; FLUPENTIXOL; SUMANIROLE; BENZIMIDAZOLE DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; DRD2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR CHANGE; CELL ACTIVITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG SELF ADMINISTRATION; DRUG SENSITIVITY; HABENULA; LATENT PERIOD; LATERAL HABENULA; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM; AGONISTS; ANIMAL; ANXIETY; CHEMICALLY INDUCED; COCAINE DEPENDENCE; CONFLICT; DISEASE MODEL; DRUG EFFECTS; INDWELLING CATHETER; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANXIETY; BENZIMIDAZOLES; CATHETERS, INDWELLING; COCAINE; COCAINE-RELATED DISORDERS; CONFLICT (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; FLUPENTHIXOL; HABENULA; MALE; MOTOR ACTIVITY; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SELF ADMINISTRATION;

EID: 84968820498     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2016.05.002     Document Type: Article

References (93)

1. Allen Institute for Brain Science© Allen Mouse Brain Atlas [Internet] 2015, Available from: http://mouse.brain-map.org.
2. Amat J., Sparks P.D., Matus-Amat P., Griggs J., Watkins L.R., Maier S.F. The role of the habenular complex in the elevation of dorsal raphé nucleus serotonin and the changes in the behavioral responses produced by uncontrollable stress. Brain Res. 2001, 917:118-126.
3. Anthony J.C., Tien A.Y., Petronis K.R. Epidemiologic evidence on cocaine use and panic attacks. Am. J. Epidemiol. 1989, 129:543-549.
4. Aston-Jones G., Harris G.C. Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 2004, 47(Suppl 1):167-179.
5. Aston-Jones G., Kalivas P.W. Brain norepinephrine rediscovered in addiction research. Biol. Psychiatry 2008, 63:1005-1006.
6. Balcita-Pedicino J.J., Omelchenko N., Bell R., Sesack S.R. The inhibitory influence of the lateral habenula on midbrain dopamine cells: ultrastructural evidence for indirect mediation via the rostromedial mesopontine tegmental nucleus. J. Comp. Neurol. 2011, 519:1143-1164.
7. Bardo M.T., Rowlett J.K., Harris M.J. Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neuroscience and Biobehavioral Reviews 1995, 19:39-51.
8. Blanchard D.C., Blanchard R.J. Cocaine potentiates defensive behaviors related to fear and anxiety. Neurosci. Biobehav. Rev. 1999, 23:981-991.
9. Boutrel B., Koob G.F. What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 2004, 15:1181-1194.
10. Bromberg-Martin E.S., Hikosaka O. Lateral habenula neurons signal errors in the prediction of reward information. Nat. Neurosci. 2011, 14:1209-1216.
11. Browning J.R., Jansen H.T., Sorg B.A. Inactivation of the paraventricular thalamus abolishes the expression of cocaine conditioned place preference in rats. Drug Alcohol Depend. 2014, 134:387-390.
12. Caldecott-Hazard S., Mazziotta J., Phelps M. Cerebral correlates of depressed behavior in rats: visualized using 14C-2-deoxyglucose autoradiography. J. Neurosci. 1988, 8:1951-1961.
13. Carr G.D., Fibiger H.C., Phillips A.G. Conditioned place preference as a measure of drug reward 1989, Clarendon Press, Oxford.
14. Childress A., Ehrman R., McLellan A.T., O'Brien C. Conditioned craving and arousal in cocaine addiction: a preliminary report. NIDA Res. Monogr. 1988, 81:74-80.
15. Creese I., Sibley D.R., Hamblin M.W., Leff S.E. The classification of dopamine receptors: relationship to radioligand binding. Annu. Rev. Neurosci. 1983, 6:43-71.
16. Crowley T.J., Mikulich S.K., Williams E.A., Zerbe G.O., Ingersoll N.C. Cocaine, social behavior: and alcohol-solution drinking in monkeys. Drug Alcohol Depend. 1992, 29:205-223.
17. Dackis C.A., O'Brien C.P. Cocaine dependence: a disease of the brain's reward centers. J. Subst. Abuse Treat. 2001, 21:111-117.
18. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:5274-5278.
19. Duvauchelle C.L., Levitin M., MacConell L.A., Lee L.K., Ettenberg A. Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward. Brain Res. 1992, 576:104-110.
20. Ettenberg A. Opponent process properties of self-administered cocaine. Neurosci. Biobehav. Rev. 2004, 27:721-728.
21. Ettenberg A. The runway model of drug self-administration Pharmacology. Biochem. Behav. 2009, 91:271-277.
22. Ettenberg A., Formenko V., Kaganovsky K., Shelton K., Wenzel J.M. On the positive and negative affective responses to cocaine and their relation to drug self-administration in rats. Psychopharmacology 2015, 232:2363-2375.
23. Ettenberg A., Geist T.D. An animal model for investigating the anxiogenic properties of self-administered cocaine. Psychopharmacology 1991, 103:455-461.
24. Ettenberg A., Geist T.D. Qualitative and quantitative differences in the operant runway behavior of cocaine and heroin reinforced rats. Pharmacol. Biochem. Behav. 1992, 44:191-198.
25. Ettenberg A., Pettit H.O., Bloom F.E., Koob G.F. Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 1982, 78:204-209.
26. Ettenberg A., Ofer O.A., Mueller C.L., Waldroup S., Cohen A., Ben-Shahar O. Inactivation of the dorsal raphé nucleus reduces the anxiogenic response of rats running an alley for intravenous cocaine. Pharmacol. Biochem. Behav. 2011, 97:632-639.
27. Ettenberg A., Raven M.A., Danluck D.A., Necessary B.D. Evidence for opponent-process actions of intravenous cocaine. Pharmacology, Biochemistry, and Behavior 1999, 64:507-512.
28. Fernando A.B., Economidou D., Theobald D.E., Zou M.F., Newman A.H., Spoelder M., Caprioli D., Moreno M., Hipolito L., Aspinall A.T., Robbins T.W., Dalley J.W. Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. Psychopharmacology 2012, 219:341-352.
29. Fischman M.W., Schuster C.R., Resnekov L., Shick J.F., Krasnegor N.A., Fennell W., Freedman D.X. Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch. Gen. Psychiatry 1976, 33:983-989.
30. Friedman A., Lax E., Dikshtein Y., Abraham L., Flaumenhaft Y., Sudai E., Ben-Tzion M., Ami-Ad L., Yaka R., Yadid G. Electrical stimulation of the lateral habenula produces enduring inhibitory effect on cocaine seeking behavior. Neuropharmacology 2010, 59:452-459.
31. Gao D.M., Hoffman D., Benabid A.L. Simultaneous recording of spontaneous activities and nociceptive responses from neurons in the pars compacta of substantia nigra and in the lateral habenula. Eur. J. Neurosci. 1996, 8:1474-1478.
32. Garcia-Cabezas M.A., Martinez-Sanchez P., Sanchez-Gonzalez M.A., Garzon M., Cavada C. Dopamine innervation in the thalamus: monkey versus rat. Cereb. Cortex 2009, 19:424-434.
33. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science 1991, 251:1580-1586.
34. Geist T.D., Ettenberg A. A simple method for studying intravenous drug reinforcement in a runaway. Pharmacol. Biochem. Behav. 1990, 36:703-706.
35. Geist T.D., Ettenberg A. Concurrent positive and negative goal box events produce runway behaviors comparable to those of cocaine reinforced rats. Pharmacol. Biochem. Behav. 1997, 57:145-150.
36. George F.R., Goldberg S.R. Genetic approaches to the analysis of addiction processes. Trends Pharmacol. Sci. 1989, 10:78-83.
37. Good C.H., Wang H., Chen Y.H., Mejias-Aponte C.A., Hoffman A.F., Lupica C.R. Dopamine D4 receptor excitation of lateral habenula neurons via multiple cellular mechanisms. Journal of Neuroscience 2013, 33:16853-16864.
38. Gottesfeld Z. Origin and distribution of noradrenergic innervation in the habenula: a neurochemical study. Brain Res. 1983, 275:299-304.
39. Gruber C., Kahl A., Lebenheim L., Kowski A., Dittgen A., Veh R.W. Dopaminergic projections from the VTA substantially contribute to the mesohabenular pathway in the rats. Neurosci. Lett. 2007, 427:165-170.
40. Hsu D.T., Kirouac G.J., Zubieta J.K., Bhatnagar S. Contributions of the paraventricular thalamic nucleus in the regulation of stress, motivation, and mood. Front. Behav. Neurosci. 2014, 8:73.
41. Isaac W.L., Nonneman A.J., Neisewander J., Landers T., Bardo M.T. Prefrontal cortex lesions differentially disrupt cocaine-reinforced conditioned place preference but not conditioned taste aversion. Behav. Neurosci. 1989, 103:345-355.
42. James M.H., Charnley J.L., Jones E., Levi E.M., Yeoh J.W., Flynn J.R., Smith D.W., Dayas C.V. Cocaine- and amphetamine-regulated transcript (CART) signaling within the paraventricular thalamus modulates cocaine-seeking behaviour. PLoS One 2010, 5(9). 10.1371/journal.pone.0012980.
43. Jhou T.C., Fields H.L., Baxter M.G., Saper C.B., Holland P.C. The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron 2009, 61:786-800.
44. Jhou T.C., Geisler S., Marinelli M., Degarmo B.A., Zahm D.S. The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta. J. Comp. Neurol. 2009, 513:566-596.
45. Jhou T.C., Good C.H., Rowley C.S., Xu S.P., Wang H., Burnham N.W., Hoffman A.F., Lupica C.R., Ikemoto S. Cocaine drives aversive conditioning via delayed activation of dopamine-responsive habenular and midbrain pathways. J. Neurosci. 2013, 33:7501-7512.
46. Kaufling J., Veinante P., Pawlowski S.A., Freund-Mercier M.J., Barrot M. Afferents to the GABAergic tail of the central tegmental area in the rat. J. Comp. Neurol. 2009, 513:597-621.
47. Koffarnus M.N., Newman A.H., Grundt P., Rice K.C., Woods J.H. Effects of selective dopaminergic compounds on a delay-discounting task. Behav. Pharmacol. 2011, 22:300-311.
48. Kowski A.B., Veh R.W., Weiss T. Dopaminergic activation excites rat lateral habenular neurons in vivo. Neuroscience 2009, 161:1154-1165.
49. Lecca S., Meye F.J., Mameli M. The lateral habenula in addiction and depression: an anatomical: synaptic and behavioral overview. Eur. J. Neurosci. 2014, 39:1170-1178.
50. Lein E.S., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445:168-176. 10.1038/nature0545.
51. Li S., Shi Y., Kirouac G.J. They hypothalamus and periaqueductal gray are the sources of dopamine fibers in the paraventricular nucleus of the thalamus in the rat. Front. Neuroanat. 2014, 8:136.
52. Li X., Qi J., Yamaguchi T., Wang H.L., Wang M. Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties. Brain Struct. Funct. 2013, 218:1159-1176.
53. Li Y.Q., Takada M., Shinonaga Y., Mizuno N. The sites of origin of dopaminergic afferent fibers to the lateral habenular nucleus in the rat. J. Comp. Neurol. 1993, 333:118-133.
54. Mahler S.V., Aston-Jones G.S. Fos activation of selective afferents to ventral tegmental area during cue-induced reinstatement of cocaine seeking in rats. Journal of Neuroscience 2012, 32:13309-13326.
55. Matsumoto M., Hikosaka O. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 2007, 447:1111-1115.
56. Matzeu A., Weiss F., Martin-Fardon R. Transient inactivation of the posterior paraventricular nucleus of the thalamus blocks cocaine-seeking behavior. Neuroscience Letters 2015, 608:34-39.
57. McCall R.B., Lookingland K.J., Bédard P.J., Huff R.M. Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease. Journal of Pharmacology and Experimental Therapeutics 2005, 314:1248-1256.
58. Meye F.J., Lecca S., Valentinova K., Mameli M. Synaptic and cellular profile of neurons in the lateral habenula. Frontiers in Human Neuroscience 2013, 7. Article 860.
59. Millan E.Z., Marchant N.J., McNally G.P. Extinction of drug seeking. Behavioural Brain Research 2011, 217:454-462.
60. Morency M.A., Beninger R.J. Dopaminergic substrates of cocaine-induced place conditioning. Brain Research 1986, 399:33-41.
61. Moscarello J.M., Ben-Shahar O., Ettenberg A. External incentives and internal states guide goal-directed behavior via the differential recruitment of the nucleus accumbens and the medial prefrontal cortex. Neuroscience 2010, 170:468-477.
62. Murphy C.A., DiCamillo A.M., Haun F., Murray M. Lesion of the habenular efferent pathway produces anxiety and locomotor hyperactivity in rats: a comparison of the effects of neonatal and adult lesions. Behavioral Brain Research 1996, 81:43-52.
63. 3H-cis-flupenthixol binding in rat striatum. Life Sciences 1983, 33:2179-2186.
64. Newman-Tancredi A., Audinot-Bouchez V., Gobert A., Millan M.J. Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. European Journal of Pharmacology 1997, 319:379-383.
65. Neumann P.A., Ishikawa M., Otaka M., Huang Y.H., Schlüter O.M., Dong Y. Increased excitability of lateral habenula neurons in adolescent rats following cocaine self-administration. Int. J. Neuropsychopharmacol. 2015, 18:1-10.
66. O'Brien C.P., Childress A.R., Ehrman R., Robins S.J. Conditioning factors in drug abuse: can they explain compulsion?. Journal of Psychopharmacology 1998, 12:15-22.
67. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Elsevier Academic, New York, NY.
68. Pettit H.O., Ettenberg A., Bloom F.E., Koob G.F. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 1984, 84:167-173.
69. Raven M.A., Necessary B.D., Danluck D.A., Ettenberg A. Comparison of the reinforcing and anxiogenic effects of intravenous cocaine and cocaethylene. Experimental and Clinical Psychopharmacology 2000, 8:117-124.
70. Resnick R.B., Kestenbaum R.S., Schwartz L.K. Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes. Science 1977, 195:696-698.
71. Resnick R.B., Resnick E.B. Cocaine abuse and its treatment. Psychiatric Clinics of North America 1984, 7:713-728.
72. Roberts D.C., Koob G.F. Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacology Biochemistry and Behavior 1982, 17:901-904.
73. Roberts D.C., Corcoran M.E., Fibiger H.C. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacology, Biochemistry, and Behavior 1977, 6:615-620.
74. Rogerio R., Takahashi R.N. Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze. Pharmacology Biochemistry and Behavior 1992, 43:631-633.
75. Root D.H., Hoffman A.F., Good C.H., Zhang S., Gigante E., Lupica C.R., Morales M. Norepinephrine activates dopamine D4 receptors in the rat lateral habenula. Journal of Neuroscience 2015, 35:3460-3469.
76. Rosenow D.J., Martin R.A., Eaton C.A., Monti P.M. Cocaine craving as a predictor of treatment attrition and outcomes after residential treatment for cocaine dependence. Journal for the Study of Alcohol and Drugs 2007, 68:641-648.
77. Shen X., Ruan X., Zhao H. Stimulation of midbrain dopaminergic structures modifies firing rates of rat lateral habenula neurons. PLoS One 2012, 7:34323. Article.
78. Skagerberg G., Lindvall O., Björklund A. Origin: course and termination of mesohabenular dopamine pathway in the rat. Brain Research 1984, 307:99-108.
79. Smith R.J., Aston-Jones G. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Structure and Function 2008, 213:43-61.
80. Spyraki C., Nomikos G.G., Varonos D.D. Intravenous cocaine-induced place preference: attenuation by haloperidol. Behavioral Brain Research 1987, 26:57-62.
81. Stamatakis A.M., Jennings J.H., Ung R.L., Blair G.A., Weinberg R.J., Neve R.L., Boyce F., Mattis J., Ramakrishnan C., Deisseroth K., Stuber G.D. A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote reward. Neuron 2013, 80:1039-1053.
82. Stamatakis A.M., Stuber G.D. Activation of lateral habenula inputs to the ventral midbrain promotes behavioral avoidance. Nature Neuroscience 2012, 15:1105-1107.
83. Takada M., Campbell K.J., Moriizumi T., Hattori T. On the origin of the dopaminergic innervation of the paraventricular thalamic nucleus. Neuroscience Letters 1990, 115:33-36.
84. Veeneman M.M., Boleij H., Broekhoven M.H., Snoeren E.M., Guitart Masip M., Cousijn J., et al. Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine. Psychopharmacology 2011, 214:863-876.
85. Velasquez K.M., Molfes e D.L., Salas R. The role of the habenula in drug addiction. Frontiers in Human Neuroscience 2014, 8:174. Article.
86. Wamsley J.K., Gehlert D.R., Fillous F.M., Dawson T.M. Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain. Journal of Chemical Neuroanatomy 1989, 2:119-137.
87. Weber M., Chang W.L., Breier M.R., Yang A., Millan M.J., Swerdlow N.R. The effects of the dopamine D2 agonist sumanirole on pre-pulse inhibition in rats. European Neuropsychopharmacology 2010, 20:421-425.
88. 2 dopamine receptor mRNA in rat brain. Proceedings of the National Academy of Sciences (USA) 1991, 88:1859-1863.
89. Williamson S., Gossop M., Powis B., Griffiths P., Fountain J., Strang J. Adverse effects of stimulant drugs in a community sample of drug users. Drug and Alcohol Dependence 1997, 44:87-94.
90. Wise R.A., Newton P., Leeb K., Burnette B., Pocock D.D., Justice J.B. Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology 1995, 120:10-20.
91. Woolverton W.L. Determinants of cocaine self-administration by laboratory-animals. Ciba Found Symp 1992, 166:149-161.
92. Yang X.M., Gorman A.L., Dunn A.J., Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration -neurochemical and behavioral studies. Pharmacology Biochemistry and Behavior 1992, 41:643-650.
93. Zuo W., Chen L., Wang L., Ye J.-H. Cocaine facilitates glutamatergic transmission and activates lateral habenular neurons. Neuropharmacology 2013, 70:180-189.